For the year ending 2025-12-31, ZVSA has $347,901 in assets. $12,734,687 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 101,778 | |||
| Prepaid expenses and other current assets | 231,639 | |||
| Vendor deposits | 14,484 | |||
| Total current assets | 347,901 | |||
| Total assets | 347,901 | |||
| Accounts payable | 10,123,391 | |||
| Accrued expenses and other current liabilities | 2,611,296 | |||
| Total current liabilities | 12,734,687 | |||
| Total liabilities | 12,734,687 | |||
| Preferred stock | 1 | |||
| Common stock | 809 | |||
| Additional paid-in-capital | 125,204,509 | |||
| Accumulated deficit | -137,584,937 | |||
| Treasury stock, at cost, 7 shares at december 31, 2025 and 2024 | 7,168 | |||
| Total stockholders (deficit) equity | -12,386,786 | |||
| Total liabilities and stockholders (deficit) equity | 347,901 | |||
ZyVersa Therapeutics, Inc. (ZVSA)
ZyVersa Therapeutics, Inc. (ZVSA)